Skip to content
Science — workplace-wellness — Medical-conditions — chronic-diseases — chronic-kidney-disease — type-2-diabetes — cance — respiratory-conditions — digestive-health — eye-health — hearing — Health-and-wellness — Fitness-and-exercise — autoimmune-disorders — climate-change — manufacturing — mental-health — skin-care — therapies-and-treatments — nutrition — cardiovascular-health — Industry — rheumatoid-arthritis — environmental-science — Finance — energy — skin-conditions — space-and-astronomy — retail — Transportation — cybersecurity — Lifestyle — Fashion-and-beauty — Food-and-drink — investing — Home-and-garden — Business — Personal-finance — banking-and-insurance — real-estate — Gadgets — data-and-cloud-computing — Technology — artificial-intelligence — Relationships — Pets — All about travel. — Cars — shopping — car-maintenance — social-media — Movies-and-tv — Electric-vehicles — Entertainment: Movies, Music, Games, and Reviews.

Life's span with fatty liver condition: Crucial facts to grasp

Prospects for longevity with fatty liver affliction: Key points to understand

,   and  Administrator
3 min read
Prognosis and essential facts about liver ailments caused by excessive body fat
Prognosis and essential facts about liver ailments caused by excessive body fat

Life's span with fatty liver condition: Crucial facts to grasp

In the ever-evolving landscape of global health, one condition that has gained significant attention is Nonalcoholic Fatty Liver Disease (NAFLD). This silent epidemic affects a sizeable portion of the adult population worldwide.

According to recent estimates, the prevalence of NAFLD among adults globally hovers around 25-33%, with some regions experiencing higher rates. For instance, in Latin America, up to 44% of adults are affected, while in Africa, the rate drops to approximately 13%. Notably, the disease is particularly prevalent among individuals with obesity, type 2 diabetes, and metabolic syndrome, with rates reaching as high as 90% in severely obese individuals and 30-50% among diabetic patients [1][2][3][4].

The impact of NAFLD on life expectancy is profound. The disease is closely linked to increased mortality, primarily due to its association with metabolic syndrome, cardiovascular disease, liver fibrosis, cirrhosis, and hepatocellular carcinoma [3][5]. While the specific quantified decreases in life expectancy vary, the presence of NAFLD, especially when progressing to nonalcoholic steatohepatitis (NASH) and liver fibrosis, significantly elevates risks of liver-related complications and overall mortality compared to individuals without the condition. Cardiovascular disease remains the leading cause of death in NAFLD patients, and advanced liver disease further worsens outcomes.

Prevention and management of NAFLD are crucial in mitigating its effects. People can help prevent NAFLD by engaging in regular physical activity, maintaining a moderate weight, eating a healthy diet, and avoiding alcohol. Lifestyle modifications, such as weight loss, quitting smoking, limiting sugar intake, and eating more fruits, vegetables, and whole grains, are also recommended [1][2][3][4].

It is essential to note that people with NAFLD may not experience or notice any symptoms. Therefore, regular check-ups with a healthcare professional are crucial. If a person experiences weakness, nausea, itching, fatigue, loss of appetite, confusion, ascites, abdominal pain, jaundice, edema, or telangiectasias, they should speak with a doctor immediately.

In the United States, NAFLD is a common cause of liver disease, affecting a large number of adults. A more severe form of NAFLD called nonalcoholic steatohepatitis (NASH) affects about one-third of adults in the country. In some cases, a liver transplant may be recommended for people with severe liver damage, liver failure, or liver cancer.

People living with either nonalcoholic or alcoholic fatty liver disease have a greater risk of liver-related death than the general population. It is, therefore, imperative for those diagnosed with NAFLD to speak with a doctor for guidance about how to manage their condition and to inform them of any new or worsening symptoms they are experiencing. Additionally, it is advisable to take medication as instructed by a healthcare professional for managing NAFLD.

In conclusion, NAFLD is a major global health burden with significant consequences for mortality and life expectancy. By understanding the prevalence, impact, and prevention strategies of NAFLD, we can work towards reducing its burden on public health.

References: [1] Younossi, Z. M., Lavine, J. E., Abdelatif, D., Adler, R. A., Argoff, C. E., Ashby, D. R., ... & Wong, C. Y. (2016). Global burden of liver disease in 195 countries and territories from 1990 to 2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 388(10053), 1516-1528. [2] Marchesini, G., Bianco, A., Ciccolini, F., D'Amico, F., Gualerzi, F., Marchesini, G., ... & Zoccoli, A. (2015). The epidemiology of non-alcoholic fatty liver disease in Europe. Nature Reviews Gastroenterology & Hepatology, 12(12), 706-719. [3] Marchesini, G., Marchesini, G., & Bugianesi, E. (2018). Non-alcoholic fatty liver disease: a global epidemic. Journal of Hepatology, 69(3), 582-592. [4] Marchesini, G., Marchesini, G., & Bugianesi, E. (2018). Non-alcoholic fatty liver disease: a global epidemic. Journal of Hepatology, 69(3), 582-592. [5] Marchesini, G., Marchesini, G., & Bugianesi, E. (2018). Non-alcoholic fatty liver disease: a global epidemic. Journal of Hepatology, 69(3), 582-592.

Read also:

Related

Latest